(Q52967287)

10 May 2018

title

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. (English)

1 reference

10 May 2018

adaptive radiation therapy

main subject

0 references

1 reference

Richard M Hoffman

3

0 references

David F. Penson

object named as

David F Penson

6

0 references

author name string

Arnold L Potosky

1

1 reference

10 May 2018

William W Davis

2

1 reference

10 May 2018

Janet L Stanford

4

1 reference

10 May 2018

Robert A Stephenson

5

1 reference

10 May 2018

Linda C Harlan

7

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 September 2004

1 reference

10 May 2018

Journal of the National Cancer Institute

published in

1 reference

10 May 2018

volume

96

1 reference

10 May 2018

issue

18

1 reference

10 May 2018

page(s)

1358-1367

1 reference

10 May 2018

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Population-based study of long-term survival in patients with clinically localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Quality of life after radical prostatectomy or watchful waiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Adjustment to cancer - coping or personal transition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Estimating causal effects from large data sets using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Predictive margins with survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Screening for prostate cancer. A decision analytic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Defining sexual outcomes after treatment for localized prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Time course and predictors of symptoms after primary prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Trends in the utilization of androgen-deprivation therapy for patients with prostate carcinoma suggest an effect on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

National practice patterns and time trends in androgen ablation for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH259

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH259

1 reference

10 May 2018

1 reference

10 May 2018